EFFECTS OF PRAZOSIN AND PROPRANOLOL ON SERUM-LIPIDS IN PATIENTS WITH ESSENTIAL-HYPERTENSION

被引：51

作者：

LOWENSTEIN, J

NEUSY, AJ

机构：

来源：

AMERICAN JOURNAL OF MEDICINE | 1984年 / 76卷 / 2A期

关键词：

D O I：

10.1016/0002-9343(84)90960-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：79 / 84

页数：6

共 20 条

[1]

AMES RP, 1976, LANCET, V1, P721

[2]

[Anonymous], 1982, JAMA, V248, P1465

[3] METABOLIC CONSEQUENCES OF ATENOLOL AND PROPRANOLOL IN TREATMENT OF ESSENTIAL HYPERTENSION [J].

DAY, JL ;

SIMPSON, N ;

METCALFE, J ;

PAGE, RL .

BRITISH MEDICAL JOURNAL, 1979, 1 (6156) :77-80

[4]

Effects of treatment on morbidity in hypertension, 1970, JAMA-J AM MED ASSOC, V213, P1143

[5]

GEMMA G, 1982, J CARDIOVASC PHARM, V4, pS233

[6] SERUM LIPOPROTEIN LEVELS DURING CHLORTHALIDONE THERAPY - A VETERANS-ADMINISTRATION-NATIONAL-HEART-LUNG-AND-BLOOD-INSTITUTE COOPERATIVE STUDY ON ANTIHYPERTENSIVE THERAPY - MILD HYPERTENSION [J].

GOLDMAN, AI ;

STEELE, BW ;

SCHNAPER, HW ;

FITZ, AE ;

FROHLICH, ED ;

PERRY, HM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 244 (15) :1691-1695

[7] HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY [J].

GORDON, T ;

CASTELLI, WP ;

HJORTLAND, MC ;

KANNEL, WB ;

DAWBER, TR .

AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) :707-714

[8]

HAVARD CWH, 1982, J CARDIOVASC PHARM, V4, pS238

[9] SERUM CHOLESTEROL, LIPOPROTEINS, AND RISK OF CORONARY HEART DISEASE - FRAMINGHAM STUDY [J].

KANNEL, WB ;

CASTELLI, WP ;

GORDON, T ;

MCNAMARA, PM .

ANNALS OF INTERNAL MEDICINE, 1971, 74 (01) :1-+

[10]

KATHER H, 1982, J CARDIOVASC PHARM, V4, pS245

← 1 2 →